The UK manufacturer of abacavir says that potent
enzyme inducers such as
phenobarbital (and therefore probably primidone) may slightly decrease abacavir concentrations.
The
clinical significance of this prediction is unclear but it may be prudent to monitor to ensure abacavir is effective.